Prognostic Value of Serum Total Bilirubin after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome

Table 1

Demographic, clinical, and laboratory characteristics according to STB.

Variable	Group A	Group B	Group C	P-value
	(N= 923)	(N= 924)	(N= 923)
Age, year	60 ± 11.47	60 ± 11.32	60 ± 11.48	0.514
Men, n (%)	645 (69.88 %)	638 (69.05 %)	652 (70.64 %)	0.757
BMI, kg/m^2				0.323
Lower than normal, n (%)	315 (38.60 %)	318 (41.68 %)	283 (36.71 %)
Normal, n (%)	434 (53.19 %)	386 (50.59 %)	430 (55.77 %)
Higher than normal, n (%)	67 (8.21 %)	59 (7.73%)	58 (7.52 %)
Clinical variables
Hypertension, n (%)	585 (63.38 %)	561 (60.71 %)	551 (59.70 %)	0.245
Diabetes, n (%)	177 (19.22 %)	126 (13.76 %)	144 (15.67 %)	0.006
Smoking, n (%)	418 (46.24 %)	446 (49.06 %)	433 (47.53 %)	0.483
Hyperlipidemia, n (%)	322 (34.92 %)	302 (32.68 %)	305 (33.08 %)	0.554
Renal insufficiency, n (%)	508 (55.52%)	448 (48.85%)	491 (53.60%)	0.013
LVEF, n (%)	50. 89 ± 11.13	50. 88 ± 11.20	50.75 ± 10.92	0.954
Laboratory values
Troponin, ng/mL	0.40(0.03, 3.6)	1.20(0.31,4.70)	0.98 (0.03,4.60)	0.024
Triglycerides, mmol/l	1.78 ± 1.30	1.75 ± 1.20	1.70 ± 1.09	0.290
LDL, mmol/l	2.68 ± 0.72	2.75 ± 0.80	2.67 ± 0.75	0.067
HDL, mmol/l	1.19 ± 0.33	1.20 ± 0.32	1.20 ± 0.31	0.723
TC, mmol/l	4.65 ± 1.01	4. 71 ± 1.04	4.61 ± 1.00	0.094
HBA1C, n (%)	6.34 ± 1.91	5.89 ± 1.87	5.87 ± 1.79	0.002
Hemoglobin, g/L	136.34 ± 16.96	137.84 ± 16.70	137.82 ± 16.68	0.091
Platelet, n/mm^3	230.51 ± 62.02	226.03 ± 62.09	226.23 ± 64.24	0.223
STB, μmol/l	6.73 ± 2.00	12.64 ± 1.61	17.76 ± 1.41	<.001
SDB, μmol/l	3.52 ± 1.56	4.15 ± 1.18	4.53 ± 1.61	<.001
AST, u/L	28 (19, 35)	29 (19, 37)	29 (21, 37)	0.052
ALT, u/L	30 (19, 40)	32 (21, 43)	32 (20, 43)	0.007
Previous medications
ACEI/ARB, n (%)	296 (32.22%)	286 (30.25%)	277 (30.01%)	0.633
β-blocker, n (%)	249 (26.98%)	233 (25.22%)	241 (26.11%)	0.690
Aspirin, n (%)	283 (30.66%)	432 (46.75%)	417 (45.18%)	<.001
Statins, n (%)	322 (34.89%)	453 (49.03%)	435 (47.13%)	<.001

LVEF: left ventricular ejection fraction; LDL: low-density lipoprotein; HDL: high-density lipoprotein; TC: total cholesterol; STB: serum total bilirubin; SDP: serum direct bilirubin; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ACEI: angiotensin-converting enzyme inhibitor; and ARB: angiotensin II receptor blockade.